Ferroptosis: A potential therapeutic target in autoimmune disease (Review)
- PMID: 37408857
- PMCID: PMC10318600
- DOI: 10.3892/etm.2023.12067
Ferroptosis: A potential therapeutic target in autoimmune disease (Review)
Abstract
Ferroptosis is a distinct type of regulated cell death characterized by iron overload and lipid peroxidation. Ferroptosis is regulated by numerous factors and controlled by several mechanisms. This cell death type has a relationship with the immune system, which may be regulated by damage-associated molecular patterns. Ferroptosis participates in the progression of autoimmune diseases, including autoimmune hepatitis, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, Parkinson's Disease, psoriasis and insulin-dependent diabetes mellitus. The present review summarizes the role of ferroptosis in autoimmune disorders and discusses ferroptosis as a potential therapeutic target for autoimmune disease.
Keywords: autoimmune disease; ferroptosis; immune system; therapeutic target.
Copyright: © Shen et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures

Similar articles
-
Targeting ferroptosis in autoimmune diseases: Mechanisms and therapeutic prospects.Autoimmun Rev. 2024 Nov;23(11):103640. doi: 10.1016/j.autrev.2024.103640. Epub 2024 Sep 13. Autoimmun Rev. 2024. PMID: 39278299 Review.
-
Programmed cell death in autoimmune diseases: ferroptosis.Ann Biol Clin (Paris). 2024 Apr 19;82(1):33-42. doi: 10.1684/abc.2024.1866. Ann Biol Clin (Paris). 2024. PMID: 38638017 Review.
-
Ferroptosis as an emerging target in rheumatoid arthritis.Front Immunol. 2023 Oct 19;14:1260839. doi: 10.3389/fimmu.2023.1260839. eCollection 2023. Front Immunol. 2023. PMID: 37928554 Free PMC article. Review.
-
Disrupting the immune homeostasis: the emerging role of macrophage ferroptosis in autoimmune diseases.Int Immunopharmacol. 2025 Jun 5;157:114745. doi: 10.1016/j.intimp.2025.114745. Epub 2025 May 3. Int Immunopharmacol. 2025. PMID: 40319750 Review.
-
Advances in the study of ferroptosis and its relationship to autoimmune diseases.Int Immunopharmacol. 2024 Oct 25;140:112819. doi: 10.1016/j.intimp.2024.112819. Epub 2024 Aug 3. Int Immunopharmacol. 2024. PMID: 39096870 Review.
Cited by
-
Ferroptosis: Disease Associations and Therapeutic Target Exploration.J Mol Neurosci. 2025 Jun 14;75(2):76. doi: 10.1007/s12031-025-02369-w. J Mol Neurosci. 2025. PMID: 40515876 Review.
-
Editorial: Mitochondrial dysfunction in inflammation and autoimmunity.Front Immunol. 2023 Oct 4;14:1304315. doi: 10.3389/fimmu.2023.1304315. eCollection 2023. Front Immunol. 2023. PMID: 37860005 Free PMC article. No abstract available.
-
FKBP3, a poor prognostic indicator, promotes the progression of LUAD via regulating ferroptosis and immune infiltration.Medicine (Baltimore). 2024 Jun 28;103(26):e38606. doi: 10.1097/MD.0000000000038606. Medicine (Baltimore). 2024. PMID: 38941396 Free PMC article.
-
Ferroptosis in immune chaos: Unraveling its impact on disease and therapeutic potential.J Physiol Biochem. 2025 May;81(2):249-272. doi: 10.1007/s13105-025-01078-7. Epub 2025 Apr 16. J Physiol Biochem. 2025. PMID: 40237936 Review.
-
Immunometabolism of ferroptosis in the tumor microenvironment.Front Oncol. 2024 Aug 12;14:1441338. doi: 10.3389/fonc.2024.1441338. eCollection 2024. Front Oncol. 2024. PMID: 39188677 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources